메뉴 건너뛰기




Volumn 7, Issue 2, 2012, Pages 141-149

LDL lowering in peripheral arterial disease: Are there benefits beyond reducing cardiovascular morbidity and mortality?

Author keywords

claudication; HMG CoA reductase inhibitors; LDL C; lipid lowering; peripheral arterial disease; statin

Indexed keywords

ATORVASTATIN; BEZAFIBRATE; COLESTIPOL; EZETIMIBE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PLACEBO; SIMVASTATIN; TRIACYLGLYCEROL;

EID: 84860112755     PISSN: 17460875     EISSN: 17584302     Source Type: Journal    
DOI: 10.2217/clp.12.6     Document Type: Article
Times cited : (11)

References (58)
  • 2
    • 4043152705 scopus 로고    scopus 로고
    • Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000
    • DOI 10.1161/01.CIR.0000137913.26087.F0
    • Selvin E, Erlinger T P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey. Circulation 110, 738-743 (2004). (Pubitemid 39056275)
    • (2004) Circulation , vol.110 , Issue.6 , pp. 738-743
    • Selvin, E.1    Erlinger, T.P.2
  • 3
    • 73449118565 scopus 로고    scopus 로고
    • Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral arterial disease
    • Diehm C, Allenberg JR, Pittrow D et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral arterial disease. Circulation 120, 2053-2061 (2009).
    • (2009) Circulation , vol.120 , pp. 2053-2061
    • Diehm, C.1    Allenberg, J.R.2    Pittrow, D.3
  • 4
    • 0033593868 scopus 로고    scopus 로고
    • Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease
    • DOI 10.1001/archinte.159.4.387
    • McDermott MM, Mehta S, Greenland P. Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease. Arch. Intern. Med. 159, 387-392 (1999). (Pubitemid 29091628)
    • (1999) Archives of Internal Medicine , vol.159 , Issue.4 , pp. 387-392
    • McDermott, M.M.1    Mehta, S.2    Greenland, P.3
  • 6
    • 10844287260 scopus 로고    scopus 로고
    • The health related quality of life of people with peripheral arterial disease in the community: The Edinburgh Artery Study
    • Dumville JC, Lee AJ, Smith FB, Fowkes FGR. The health related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study. Br. J. Gen. Pract. 54(508), 639-642 (2004).
    • (2004) Br. J. Gen. Pract. , vol.54 , Issue.508 , pp. 639-642
    • Dumville, J.C.1    Lee, A.J.2    Smith, F.B.3    Fgr, F.4
  • 7
    • 0027510276 scopus 로고
    • Epidemiology of critical limb ischaemia: North Italian data
    • Catalano M. Epidemiology of critical limb ischemia: northern Italian data. Eur. J. Med. 2, 11-14 (1993). (Pubitemid 23042545)
    • (1993) European Journal of Medicine , vol.2 , Issue.1 , pp. 11-14
    • Catalano, M.1
  • 8
    • 0344844381 scopus 로고    scopus 로고
    • Peripheral arterial disease in people with diabetes
    • American Diabetes Association.
    • American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 26, 3333-3341 (2003).
    • (2003) Diabetes Care , vol.26 , pp. 3333-3341
  • 10
    • 33947608774 scopus 로고    scopus 로고
    • Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J. Vasc. Surg. 45, 645-654 (2007).
    • (2007) J. Vasc. Surg. , vol.45 , pp. 645-654
  • 13
    • 79952110879 scopus 로고    scopus 로고
    • Atherosclerotic plaque regression-The role of statin therapy
    • Sastry P, Kaski JC. Atherosclerotic plaque regression-the role of statin therapy. Drugs Today (Barc.) 46(8), 601-608 (2010).
    • (2010) Drugs Today (Barc.) , vol.46 , Issue.8 , pp. 601-608
    • Sastry, P.1    Kaski, J.C.2
  • 15
    • 80052094401 scopus 로고    scopus 로고
    • The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline
    • West AM, Anderson JD, Meyer CH et al. The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline. Atherosclerosis 218, 156-162 (2011).
    • (2011) Atherosclerosis , vol.218 , pp. 156-162
    • West, A.M.1    Anderson, J.D.2    Meyer, C.H.3
  • 17
    • 72049129430 scopus 로고    scopus 로고
    • Extended-release niacin or ezetimibe and carotid intima-media thickness
    • Taylor AJ, Villines TC, Stanek EJ et al. Extended-release niacin or ezetimibe and carotid intima-media thickness. N. Engl. J. Med. 361, 2113-2122 (2009).
    • (2009) N. Engl. J. Med. , vol.361 , pp. 2113-2122
    • Taylor, A.J.1    Villines, T.C.2    Stanek, E.J.3
  • 18
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • Pedersen T, Kjekshus J, Berg K et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383-1389 (1994). (Pubitemid 24365311)
    • (1994) Lancet , vol.344 , Issue.8934 , pp. 1383-1389
    • Pedersen, T.R.1
  • 20
    • 0042334924 scopus 로고    scopus 로고
    • Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment
    • DOI 10.1016/S0002-9149(03)00833-6
    • Aronow WS, Nayak D, Woodworth S, Ahn C. Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at 6 months and one year after treatment. Am. J. Cardiol. 92(6), 711-712 (2003). (Pubitemid 37103026)
    • (2003) American Journal of Cardiology , vol.92 , Issue.6 , pp. 711-712
    • Aronow, W.S.1    Nayak, D.2    Woodworth, S.3    Ahn, C.4
  • 22
    • 0141504333 scopus 로고    scopus 로고
    • Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease
    • DOI 10.1161/01.CIR.0000090686.57897.F5
    • Mohler ER 3rd, Hiatt WR, Creager MA. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation 108, 1481-1486 (2003). (Pubitemid 37176455)
    • (2003) Circulation , vol.108 , Issue.12 , pp. 1481-1486
    • Mohler III, E.R.1    Hiatt, W.R.2    Creager, M.A.3
  • 24
    • 33644598993 scopus 로고    scopus 로고
    • Statin use and functional decline in patients with and without peripheral arterial disease
    • Giri J, McDermott MM, Greenland P et al. Statin use and functional decline in patients with and without peripheral arterial disease. J. Am. Coll. Cardiol. 47, 998-1004 (2006).
    • (2006) J. Am. Coll. Cardiol. , vol.47 , pp. 998-1004
    • Giri, J.1    McDermott, M.M.2    Greenland, P.3
  • 25
    • 80052080530 scopus 로고    scopus 로고
    • Low-density lipoprotein lowering does not improve calf muscle perfusion, energetic or exercise performance in peripheral arterial disease
    • West AM, Anderson JD, Epstein FH et al. Low-density lipoprotein lowering does not improve calf muscle perfusion, energetic or exercise performance in peripheral arterial disease. J. Am. Coll. Cardiol. 58, 1068-1076 (2011).
    • (2011) J. Am. Coll. Cardiol. , vol.58 , pp. 1068-1076
    • West, A.M.1    Anderson, J.D.2    Epstein, F.H.3
  • 26
    • 77952576925 scopus 로고    scopus 로고
    • Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral arterial disease
    • Hiatt WR, Hirsch AT, Creager MA et al. Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral arterial disease. J. Vasc. Med. 15, 171-179 (2010).
    • (2010) J. Vasc. Med. , vol.15 , pp. 171-179
    • Hiatt, W.R.1    Hirsch, A.T.2    Creager, M.A.3
  • 27
    • 33846497950 scopus 로고    scopus 로고
    • Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
    • DOI 10.1016/j.jvs.2006.12.037, PII S0741521406022968
    • Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease. J. Vasc. Surg. 45(1 Suppl.), S5-S67 (2007). (Pubitemid 46151680)
    • (2007) Journal of Vascular Surgery , vol.45 , Issue.SUPPL.
    • Norgren, L.1    Hiatt, W.R.2    Dormandy, J.A.3    Nehler, M.R.4    Harris, K.A.5    Fowkes, F.G.R.6
  • 28
    • 84555203680 scopus 로고    scopus 로고
    • 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients with Peripheral Arterial Disease (updating the 2005 guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • Rooke TW, Hirsch AT, Misra S et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Arterial Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124, 2020-2045 (2011).
    • (2011) Circulation , vol.124 , pp. 2020-2045
    • Rooke, T.W.1    Hirsch, A.T.2    Misra, S.3
  • 29
    • 81855226412 scopus 로고    scopus 로고
    • ESC guidelines on the diagnosis and treatment of peripheral arterial diseases: Document covering atherosclerotic disease of the extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: The Task Force on the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology
    • Tendera M, Aboyans V, Bartelink ML et al. ESC guidelines on the diagnosis and treatment of peripheral arterial diseases: document covering atherosclerotic disease of the extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology. Eur. Heart J. 32(22), 2723-2724 (2011).
    • (2011) Eur. Heart J. , vol.32 , Issue.22 , pp. 2723-2724
    • Tendera, M.1    Aboyans, V.2    Bartelink, M.L.3
  • 30
    • 0035572718 scopus 로고    scopus 로고
    • Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
    • Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21, 1712-1719 (2001). (Pubitemid 34219772)
    • (2001) Arteriosclerosis, Thrombosis, and Vascular Biology , vol.21 , Issue.11 , pp. 1712-1719
    • Takemoto, M.1    Liao, J.K.2
  • 32
    • 0029121091 scopus 로고
    • Vascular function in the forearm of hypercholesterolemic patients off and on lipid-lowering medication
    • Stroes ES, Koomans HA, de Bruin TW, Rabelink TJ. Vascular function in the forearm of hypercholesterolemic patients off and on lipid-lowering medication. Lancet 326, 467-471 (1995).
    • (1995) Lancet , vol.326 , pp. 467-471
    • Stroes, E.S.1    Koomans, H.A.2    De Bruin, T.W.3    Rabelink, T.J.4
  • 33
    • 0032584177 scopus 로고    scopus 로고
    • Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
    • Laufs U, La F, Plutzky J, Liao JK. Up regulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97, 1129-1135 (1998). (Pubitemid 28152885)
    • (1998) Circulation , vol.97 , Issue.12 , pp. 1129-1135
    • Laufs, U.1    La Fata, V.2    Plutzky, J.3    Liao, J.K.4
  • 35
    • 0033186439 scopus 로고    scopus 로고
    • Effect of lipid-lowering therapy on vasomotor and endothelial function
    • Kinlay S, Plutzky J. Effect of lipid-lowering therapy on vasomotor and endothelial function. Curr. Cardiol. Rep. 1(3), 238-243 (1999).
    • (1999) Curr. Cardiol. Rep. , vol.1 , Issue.3 , pp. 238-243
    • Kinlay, S.1    Plutzky, J.2
  • 36
    • 0242349754 scopus 로고    scopus 로고
    • Endothelial Dysfunction and Cardiovascular Risk Prediction in Peripheral Arterial Disease: Additive Value of Flow-Mediated Dilation to Ankle-Brachial Pressure Index
    • DOI 10.1161/01.CIR.0000095273.92468.D9
    • Brevetti G, Silvestro A, Schiano V et al. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of fow-mediated dilation to ankle brachial pressure index. Circulation 108, 2093-2098 (2003). (Pubitemid 37337585)
    • (2003) Circulation , vol.108 , Issue.17 , pp. 2093-2098
    • Brevetti, G.1    Silvestro, A.2    Schiano, V.3    Chiariello, M.4
  • 38
    • 68449096745 scopus 로고    scopus 로고
    • Physical activity during daily life and brachial artery fow-mediated dilation in peripheral arterial disease
    • Payvandi L, Dyer A, McPherson D et al. Physical activity during daily life and brachial artery fow-mediated dilation in peripheral arterial disease. Vasc. Med. 14, 193-201 (2009).
    • (2009) Vasc. Med. , vol.14 , pp. 193-201
    • Payvandi, L.1    Dyer, A.2    McPherson, D.3
  • 39
    • 8344271937 scopus 로고    scopus 로고
    • Effects of statins on vascular structure and function: A systematic review
    • DOI 10.1016/j.amjmed.2004.05.026, PII S0002934304005352
    • Balk EM, Karas RH, Jordan HS, Kupelnick B, Chew P, Lau J. Effects of statins on vascular structure and function: a systematic review. Am. J. Med. 117, 775-790 (2004). (Pubitemid 39482531)
    • (2004) American Journal of Medicine , vol.117 , Issue.10 , pp. 775-790
    • Balk, E.M.1    Karas, R.H.2    Jordan, H.S.3    Kupelnick, B.4    Chew, P.5    Lau, J.6
  • 40
    • 79959207961 scopus 로고    scopus 로고
    • Arterial dysfunction and functional performance in patients with peripheral arterial disease: A review
    • Coutinho T, Rooke TW, Kullo IJ. Arterial dysfunction and functional performance in patients with peripheral arterial disease: a review. Vasc. Med. 16, 203-211 (2011).
    • (2011) Vasc. Med. , vol.16 , pp. 203-211
    • Coutinho, T.1    Rooke, T.W.2    Kullo, I.J.3
  • 43
    • 0035912855 scopus 로고    scopus 로고
    • Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease
    • Vasa M, Fichtlscherer S, Adler K et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103, 2885-2890 (2001). (Pubitemid 32578123)
    • (2001) Circulation , vol.103 , Issue.24 , pp. 2885-2890
    • Vasa, M.1    Fichtlscherer, S.2    Adler, K.3    Aicher, A.4    Martin, H.5    Zeiher, A.M.6    Dimmeler, S.7
  • 45
    • 0032572043 scopus 로고    scopus 로고
    • Antiatherothrombotic properties of statins
    • Rosenson RS, Tagney CC. Antiatherothrombotic properties of statins. JAMA 279, 1643-1650 (1998).
    • (1998) JAMA , vol.279 , pp. 1643-1650
    • Rosenson, R.S.1    Tagney, C.C.2
  • 46
    • 37249055181 scopus 로고    scopus 로고
    • The myopathy of peripheral arterial occlusive disease: Part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction
    • DOI 10.1177/1538574407311106
    • Pipinos II, Judge AR, Selsby JT et al. The myopathy of peripheral arterial occlusive disease: Part 1. Functional and histomorphologic changes and evidence for mitochrondrial dysfunction. Vasc. Endovasc. Surg. 42(6), 481-489 (2008). (Pubitemid 350264699)
    • (2008) Vascular and Endovascular Surgery , vol.41 , Issue.6 , pp. 481-489
    • Pipinos, I.I.1    Judge, A.R.2    Selsby, J.T.3    Zhu, Z.4    Swanson, S.A.5    Nella, A.A.6    Dodd, S.L.7
  • 47
    • 42449109144 scopus 로고    scopus 로고
    • The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type
    • DOI 10.1177/1538574408315995
    • Pipinos II, Judge AR, Zhu Z et al. Basic science review: the myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy and shift in muscle fber type. Vasc. Endovasc. Surg. 42, 101-112 (2008). (Pubitemid 351559569)
    • (2008) Vascular and Endovascular Surgery , vol.42 , Issue.2 , pp. 101-112
    • Pipinos, I.I.1    Judge, A.R.2    Selsby, J.T.3    Zhu, Z.4    Swanson, S.A.5    Nella, A.A.6    Dodd, S.L.7
  • 50
    • 67849083492 scopus 로고    scopus 로고
    • Multifactorial determinants of functional capacity in peripheral arterial disease: Uncoupling of calf muscle perfusion and metabolism
    • Anderson JD, Epstein FH, Meyer CH et al. Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism. J. Am. Coll. Cardiol. 54, 628-635 (2009).
    • (2009) J. Am. Coll. Cardiol. , vol.54 , pp. 628-635
    • Anderson, J.D.1    Epstein, F.H.2    Meyer, C.H.3
  • 51
    • 39449105438 scopus 로고    scopus 로고
    • Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease
    • DOI 10.1016/j.atherosclerosis.2007.03.034, PII S0021915007002055
    • Rizzo M, Pernice V, Frasheri A, Berneis K. Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease. Atherosclerosis 197, 237-241 (2008). (Pubitemid 351273244)
    • (2008) Atherosclerosis , vol.197 , Issue.1 , pp. 237-241
    • Rizzo, M.1    Pernice, V.2    Frasheri, A.3    Berneis, K.4
  • 52
    • 0037121346 scopus 로고    scopus 로고
    • Bezafbrate in men with lower extremity arterial disease: Randomized controlled trial
    • Meade T, Zuhrie R, Cook C, Cooper J. Bezafbrate in men with lower extremity arterial disease: randomized controlled trial. BMJ 325, 1139 (2002).
    • (2002) BMJ , vol.325 , pp. 1139
    • Meade, T.1    Zuhrie, R.2    Cook, C.3    Cooper, J.4
  • 53
    • 0026086789 scopus 로고
    • Effects of colestipol-niacin therapy on human femoral atherosclerosis
    • Blankenhorn DH, Azen SP, Crawford DW et al. Effects of colestipol-niacin therapy on human femoral atherosclerosis. Circulation 83, 438-447 (1991).
    • (1991) Circulation , vol.83 , pp. 438-447
    • Blankenhorn, D.H.1    Azen, S.P.2    Crawford, D.W.3
  • 54
    • 0029831295 scopus 로고    scopus 로고
    • Impact of cholesterol reduction on peripheral arterial disease in the Program on the Surgical Control of the Hyperlipidemias (POSCH)
    • DOI 10.1016/S0039-6060(96)80016-X
    • Buchwald H, Bourgades HR, Campos CT et al. Impact of cholesterol reduction on peripheral arterial disease in the Program on the Surgical Control of the Hyperlipidemias (POSCH). Surgery 120, 672-679 (1996). (Pubitemid 26334323)
    • (1996) Surgery , vol.120 , Issue.4 , pp. 672-679
    • Buchwald, H.1    Bourdages, H.R.2    Campos, C.T.3    Nguyen, P.4    Williams, S.E.5    Boen, J.R.6    Silver, D.7
  • 55
    • 10044281651 scopus 로고    scopus 로고
    • Arterial Biology for the Investigation of the Treatment Effects of Reducing cholesterol (ARBITER) 2: A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins
    • DOI 10.1161/01.CIR.0000148955.19792.8D
    • Taylor AJ, Sullenberger LE, Lee HJ, Lee JK, Grace KA. Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: a double blind, placebo-controlled study of extended-release niacin and atherosclerosis progression in secondary prevention patients treated with statins. Circulation 110, 3512-3517 (2004). (Pubitemid 39612564)
    • (2004) Circulation , vol.110 , Issue.23 , pp. 3512-3517
    • Taylor, A.J.1    Sullenberger, L.E.2    Lee, H.J.3    Lee, J.K.4    Grace, K.A.5
  • 56
    • 35148848559 scopus 로고    scopus 로고
    • New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease
    • DOI 10.1161/01.atv.0000280571.28102.d4
    • Tsimikas S, Tsironis LD, Tselepis AD. New insights into the role of lipoprotein[a]-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 27, 2094-2099 (2007). (Pubitemid 350287235)
    • (2007) Arteriosclerosis, Thrombosis, and Vascular Biology , vol.27 , Issue.10 , pp. 2094-2099
    • Tsimikas, S.1    Tsironis, L.D.2    Tselepis, A.D.3
  • 57
    • 77953121659 scopus 로고    scopus 로고
    • Lipoprotein (a), infammation and peripheral arterial disease in a community based sample of older men and women (the InCHIANTI study)
    • Volpato S, Vigna GB, McDermott MM et al. Lipoprotein (a), infammation and peripheral arterial disease in a community based sample of older men and women (the InCHIANTI study). Am. J. Cardiol. 105(12), 1825-1830 (2010).
    • (2010) Am. J. Cardiol. , vol.105 , Issue.12 , pp. 1825-1830
    • Volpato, S.1    Vigna, G.B.2    McDermott, M.M.3
  • 58
    • 33644604710 scopus 로고    scopus 로고
    • Peripheral arterial disease in patients with diabetes
    • Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J. Am. Coll. Cardiol. 47(5), 921-929 (2006).
    • (2006) J. Am. Coll. Cardiol. , vol.47 , Issue.5 , pp. 921-929
    • Marso, S.P.1    Hiatt, W.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.